ArticleScientific reports2018

Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.

Prajakta Shinde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.